Cargando…
Impact of the Voltage-Gated Calcium Channel Antagonist Nimodipine on the Development of Oligodendrocyte Precursor Cells
Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS). While most of the current treatment strategies focus on immune cell regulation, except for the drug siponimod, there is no therapeutic intervention that primarily aims at neuroprotection and remyeli...
Autores principales: | Enders, Michael, Weier, Alicia, Chunder, Rittika, An, Young, Bremm, Franziska, Feigenspan, Andreas, Buettner, Christian, Ekici, Arif Bülent, Mingardo, Enrico, Odermatt, Benjamin, Kuerten, Stefanie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960570/ https://www.ncbi.nlm.nih.gov/pubmed/36835129 http://dx.doi.org/10.3390/ijms24043716 |
Ejemplares similares
-
Nimodipine Exerts Beneficial Effects on the Rat Oligodendrocyte Cell Line OLN-93
por: Boltz, Felix, et al.
Publicado: (2022) -
Immune monitoring of SARS-CoV-2-specific T cell and B cell responses in patients with multiple sclerosis treated with ocrelizumab
por: Groß-Albenhausen, Elina, et al.
Publicado: (2023) -
B Cells in Multiple Sclerosis and Virus-Induced Neuroinflammation
por: Chunder, Rittika, et al.
Publicado: (2020) -
The prevalence of IgG antibodies against milk and milk antigens in patients with multiple sclerosis
por: Chunder, Rittika, et al.
Publicado: (2023) -
Impact of Siponimod on Enteric and Central Nervous System Pathology in Late-Stage Experimental Autoimmune Encephalomyelitis
por: Weier, Alicia, et al.
Publicado: (2022)